SeqOne Genomics develops state-of-the-art genomics analysis tools for clinical applications in the fields of cancer and rare diseases. Its flagship product, SeqOne | Platform is a cloud-based end-to-end solution that dramatically reduces the turnaround time and cost required to deliver accurate genetic analyses, for use in mainstream medicine.
Venture Capital
Current
Europe
Financing round - Series A
Diagnostic
2022
Status
Creation Date
Number of Employees
Investment Date
Fund Name